Next Article in Journal
Previous Article in Journal
Previous Article in Special Issue
Pharmaceuticals 2010, 3(12), 3494-3521; doi:10.3390/ph3123494
Review

Obesity Drug Update: The Lost Decade?

 and *
Received: 5 October 2010; in revised form: 17 November 2010 / Accepted: 23 November 2010 / Published: 24 November 2010
(This article belongs to the Special Issue Anti-Obesity Drugs)
View Full-Text   |   Download PDF [294 KB, uploaded 24 November 2010]
Abstract: The growing worldwide obesity epidemic and obesity-related disorders present a huge unmet medical need for safe and effective anti-obesity medications. The discovery of leptin in 1994 was rapidly succeeded by a wave of related discoveries leading to the elaboration of a hypothalamic melanocortinergic neuronal circuit regulated by leptin and other central and peripheral signaling molecules to control energy homeostasis. The identification of specific neuronal subtypes along with their unique connections and expression products generated a rich target menu for anti-obesity drug discovery programs. Over the course of the last decade, several new chemical entities aimed at these targets have reached various stages or successfully completed the drug discovery/regulatory process only to be dropped or taken off the market. There are now in fact fewer options for anti-obesity drug therapies in late 2010 than were available in 2000. The challenge to discover safe and effective anti-obesity drugs is alive and well.
Keywords: obesity; anti-obesity drug targets; anti-obesity drugs; hypothalamus obesity; anti-obesity drug targets; anti-obesity drugs; hypothalamus
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Yao, F.; MacKenzie, R.G. Obesity Drug Update: The Lost Decade? Pharmaceuticals 2010, 3, 3494-3521.

AMA Style

Yao F, MacKenzie RG. Obesity Drug Update: The Lost Decade? Pharmaceuticals. 2010; 3(12):3494-3521.

Chicago/Turabian Style

Yao, Fayi; MacKenzie, Robert George. 2010. "Obesity Drug Update: The Lost Decade?" Pharmaceuticals 3, no. 12: 3494-3521.


Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert